WHO = The World Health Organization has recommended for the first time "antibody cocktail therapy", which is a therapeutic drug for the new coronavirus and administers two types of drugs at the same time to patients with mild illness.
WHO updated the guide on the treatment of new coronavirus on the 24th.
According to this, as a result of clinical trials, the treatment method called "antibody cocktail therapy" that administers two kinds of drugs made of antibodies, "casilibimab" and "imdebimab", became more severe than when general treatment was performed. The risk of hospitalization and the time it takes to recover have decreased.
On top of that, these drugs are recommended for the treatment of mildly ill patients.
WHO has so far recommended different treatments for critically ill patients, but this is the first time it has been recommended for mildly ill patients.
In Japan, "antibody cocktail therapy" using the same drug has already been approved in July for use in mildly ill patients.
However, since these drugs are expensive and the supply is limited, how to supply them to developing countries where the spread of infection is serious is an issue, and WHO donates to the companies that manufacture the drugs. It is said that it is proceeding with negotiations such as asking for.